SE7806519L - Terapeutiska medel - Google Patents
Terapeutiska medelInfo
- Publication number
- SE7806519L SE7806519L SE7806519A SE7806519A SE7806519L SE 7806519 L SE7806519 L SE 7806519L SE 7806519 A SE7806519 A SE 7806519A SE 7806519 A SE7806519 A SE 7806519A SE 7806519 L SE7806519 L SE 7806519L
- Authority
- SE
- Sweden
- Prior art keywords
- therapeutic medicines
- medicines
- therapeutic
- piperidinophthalazine
- derivatives
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- YSKBWCJNIRPTNF-UHFFFAOYSA-N 1-piperidin-1-ylphthalazine Chemical class C1CCCCN1C1=NN=CC2=CC=CC=C12 YSKBWCJNIRPTNF-UHFFFAOYSA-N 0.000 abstract 1
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 abstract 1
- 239000000496 cardiotonic agent Substances 0.000 abstract 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2358277 | 1977-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE7806519L true SE7806519L (sv) | 1978-12-04 |
Family
ID=10198020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7806519A SE7806519L (sv) | 1977-06-03 | 1978-06-02 | Terapeutiska medel |
Country Status (29)
Country | Link |
---|---|
US (1) | US4289772A (es) |
JP (1) | JPS5416488A (es) |
AR (2) | AR222013A1 (es) |
AT (2) | AT362792B (es) |
AU (1) | AU505373B1 (es) |
BE (1) | BE867727A (es) |
CA (1) | CA1111850A (es) |
DD (1) | DD137355A5 (es) |
DE (1) | DE2824064A1 (es) |
DK (1) | DK248078A (es) |
EG (1) | EG13527A (es) |
ES (4) | ES470470A1 (es) |
FI (1) | FI781753A (es) |
FR (1) | FR2392986A1 (es) |
GB (1) | GB2000136B (es) |
GR (1) | GR74402B (es) |
HU (1) | HU179745B (es) |
IL (1) | IL54842A (es) |
IN (3) | IN148482B (es) |
IT (1) | IT1094944B (es) |
LU (1) | LU79761A1 (es) |
NL (1) | NL7806016A (es) |
NO (1) | NO781935L (es) |
NZ (1) | NZ187453A (es) |
PL (3) | PL116420B1 (es) |
PT (1) | PT68126A (es) |
SE (1) | SE7806519L (es) |
SU (2) | SU856383A3 (es) |
ZA (1) | ZA783183B (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4370328A (en) * | 1977-11-03 | 1983-01-25 | Pfizer Inc. | Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines |
IL59619A0 (en) * | 1979-03-28 | 1980-06-30 | Pfizer | Phthalazine derivatives,their preparation and pharmaceutical compositions containing them |
PL129174B1 (en) * | 1980-03-01 | 1984-04-30 | Wyeth John & Brother Ltd | Process for preparing novel derivatives of piperidine |
GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
US4882354A (en) * | 1987-12-16 | 1989-11-21 | Norwich Eaton Pharmaceuticals, Inc. | N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents |
JP3169188B2 (ja) * | 1991-01-31 | 2001-05-21 | 杏林製薬株式会社 | カルバミン酸誘導体及びその製造方法 |
US5300515A (en) * | 1991-01-31 | 1994-04-05 | Kyorin Pharmaceutical Co., Ltd. | Carbamic acid derivatives and method for preparing the same |
EP0621267A1 (en) * | 1993-04-07 | 1994-10-26 | Shell Internationale Researchmaatschappij B.V. | Spiropiperidine derivatives and their use as fungicides |
WO1996036611A1 (en) * | 1995-05-19 | 1996-11-21 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
WO1998007430A1 (fr) * | 1996-08-20 | 1998-02-26 | Eisai Co., Ltd. | Medicament contre les defaillances de l'erection, renfermant un compose a base de pyridazine fondue |
US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
EP1539739B1 (en) * | 2002-08-16 | 2010-11-24 | Janssen Pharmaceutica NV | Piperidinyl compounds that selectively bind integrins |
US20040224986A1 (en) * | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
US20060019975A1 (en) * | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
TW200630337A (en) | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
WO2007085954A2 (en) * | 2006-01-27 | 2007-08-02 | Pfizer Products Inc. | Aminophthalazine derivative compounds |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
WO2007110449A1 (en) | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
TW200815353A (en) | 2006-04-13 | 2008-04-01 | Euro Celtique Sa | Benzenesulfonamide compounds and their use |
WO2007118854A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and the use thereof |
EP2026813A2 (en) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
EP1903037A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors |
EP1900731A1 (de) * | 2006-09-07 | 2008-03-19 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren |
AU2007292848A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US8399486B2 (en) | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
CN101778837A (zh) | 2007-08-07 | 2010-07-14 | 弗·哈夫曼-拉罗切有限公司 | 作为nk3受体拮抗剂的吡咯烷芳基-醚 |
MX2010001774A (es) | 2007-08-22 | 2010-03-10 | Hoffmann La Roche | Pirrolidin aril-eteres como antagonistas de receptores de nk3. |
JP2010539126A (ja) * | 2007-09-14 | 2010-12-16 | エフ.ホフマン−ラ ロシュ アーゲー | Nk3受容体アンタゴニストとしてのピペリジン誘導体 |
US8765736B2 (en) | 2007-09-28 | 2014-07-01 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
AR077014A1 (es) * | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
CN113087654B (zh) * | 2021-04-15 | 2022-12-23 | 苏州昊帆生物股份有限公司 | 哌啶-4-丁胺的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1094044A (en) * | 1965-07-12 | 1967-12-06 | Vantorex Ltd | Phthalazine derivatives |
GB1199768A (en) | 1966-10-31 | 1970-07-22 | Pfizer & Co C | Nitrogen Heterocycles and process for their preparation |
GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
GB1460389A (en) | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
-
1978
- 1978-05-15 IN IN364/DEL/78A patent/IN148482B/en unknown
- 1978-06-01 DE DE19782824064 patent/DE2824064A1/de not_active Ceased
- 1978-06-01 NZ NZ187453A patent/NZ187453A/xx unknown
- 1978-06-01 IT IT24106/78A patent/IT1094944B/it active
- 1978-06-01 GR GR56414A patent/GR74402B/el unknown
- 1978-06-01 PT PT68126A patent/PT68126A/pt unknown
- 1978-06-01 IL IL54842A patent/IL54842A/xx unknown
- 1978-06-01 BE BE188257A patent/BE867727A/xx unknown
- 1978-06-01 JP JP6627978A patent/JPS5416488A/ja active Granted
- 1978-06-01 GB GB7826202A patent/GB2000136B/en not_active Expired
- 1978-06-01 FI FI781753A patent/FI781753A/fi not_active Application Discontinuation
- 1978-06-02 AT AT0400878A patent/AT362792B/de not_active IP Right Cessation
- 1978-06-02 LU LU79761A patent/LU79761A1/fr unknown
- 1978-06-02 AR AR272434A patent/AR222013A1/es active
- 1978-06-02 NL NL7806016A patent/NL7806016A/xx not_active Application Discontinuation
- 1978-06-02 SE SE7806519A patent/SE7806519L/xx unknown
- 1978-06-02 NO NO781935A patent/NO781935L/no unknown
- 1978-06-02 CA CA304,700A patent/CA1111850A/en not_active Expired
- 1978-06-02 PL PL1978217896A patent/PL116420B1/pl unknown
- 1978-06-02 ZA ZA00783183A patent/ZA783183B/xx unknown
- 1978-06-02 FR FR7816545A patent/FR2392986A1/fr active Granted
- 1978-06-02 PL PL1978217897A patent/PL116437B1/pl unknown
- 1978-06-02 ES ES470470A patent/ES470470A1/es not_active Expired
- 1978-06-02 SU SU782624349A patent/SU856383A3/ru active
- 1978-06-02 AU AU36839/78A patent/AU505373B1/en not_active Expired
- 1978-06-02 HU HU78PI629A patent/HU179745B/hu unknown
- 1978-06-02 DD DD78205751A patent/DD137355A5/xx unknown
- 1978-06-02 PL PL1978207337A patent/PL113208B1/pl unknown
- 1978-06-02 DK DK248078A patent/DK248078A/da not_active Application Discontinuation
- 1978-06-03 EG EG354/78A patent/EG13527A/xx active
-
1979
- 1979-03-01 ES ES478201A patent/ES478201A1/es not_active Expired
- 1979-03-01 ES ES478200A patent/ES478200A1/es not_active Expired
- 1979-03-01 ES ES478199A patent/ES478199A1/es not_active Expired
- 1979-06-18 SU SU792777649A patent/SU862826A3/ru active
- 1979-12-13 US US06/103,342 patent/US4289772A/en not_active Expired - Lifetime
-
1980
- 1980-02-12 AR AR279935A patent/AR223999A1/es active
- 1980-05-20 IN IN368/DEL/80A patent/IN149550B/en unknown
- 1980-06-10 AT AT0305080A patent/AT363096B/de not_active IP Right Cessation
-
1981
- 1981-01-13 IN IN19/DEL/81A patent/IN149973B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7806519L (sv) | Terapeutiska medel | |
SE7805954L (sv) | Terapeutiska medel | |
IT7869453A0 (it) | Segnapassi cardiaco per il trattamento dell aritmia | |
DK445978A (da) | Chromanderivater deres fremstilling og anvendelsesom insecticider og acaricider | |
IT1096306B (it) | Derivati di idantoina ad azione terapeutica e relativo procedimento di preparazione | |
SE7809645L (sv) | Hjertstimulator | |
SE7802782L (sv) | Hjertstimulator | |
NO148148C (no) | Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater | |
NO156611C (no) | Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre. | |
DK22978A (da) | Laegemiddelsproejte | |
AT344309B (de) | Kuenstliche herzkammer | |
SE7804087L (sv) | Hjertstimulator | |
NO150482C (no) | Mellomprodukter for fremstilling av terapeutisk aktive antrakinon-derivater | |
SE7800351L (sv) | Hjertstimulator | |
SE7809373L (sv) | Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat | |
NL7801005A (nl) | Derivaten van meta-sulfonamido-benzamide. | |
SE7803007L (sv) | Hjertstimulator | |
SE7601894L (sv) | Terapeutiskt medel | |
SE7811888L (sv) | Hjertstimulator | |
SE7809887L (sv) | Terapeutiska medel | |
SE432762B (sv) | Vissa fungicida n-acylderivat av alfa-anilino-propion-syratioestrar samt anvendning derav som fungicider | |
IT7821862A0 (it) | Derivati di acidi ossi-alcanoici. | |
FR2313074A1 (fr) | Diastereoisomeres de derives phenylaminoethanol | |
NO780644L (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater | |
SE7804545L (sv) | Forfarande for behandling av cereala plantor |